Listed

Sabra Health Care REIT, Inc.

SBRANasdaqCIK 1492298Real estateFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$128.8mRevenue, Q2 FY2026, three months to 2026-06-30$128.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 3, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$128.8mRevenue, Q2 FY2026, three months to 2026-06-30$128.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure+63.1% on a year earlier
  • Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
  • Operating marginnot reported (Operating income not reported)No year-earlier figure to compare
  • Net margin−19.6%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$25.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Revenue: $128.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure−102.5 pts on a year earlier
  • Diluted EPS−$0.10Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figureSign changed from a year earlier
  • Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare

Last eight quarters

Full statements
Revenue$128.8mNet margin −19.6%
Diluted EPS−$0.10, Q2 FY2026
Sabra Health Care REIT, Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m73.7Revenue, Q3 FY2024, three months to 2024-09-30$73.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure76.9Revenue, Q4 FY2024, three months to 2024-12-31$76.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure77.4Revenue, Q1 FY2025, three months to 2025-03-31$77.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure79.0Revenue, Q2 FY2025, three months to 2025-06-30$79.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure92.0Revenue, Q3 FY2025, three months to 2025-09-30$92.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure108Revenue, Q4 FY2025, three months to 2025-12-31$108.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure117Revenue, Q1 FY2026, three months to 2026-03-31$116.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure129Revenue, Q2 FY2026, three months to 2026-06-30$128.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)
Net margin%40.4%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $29.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Revenue: $73.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure60.7%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $46.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Revenue: $76.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure52.0%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $40.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Revenue: $77.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure83.0%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $65.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Revenue: $79.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure24.5%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $22.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Revenue: $92.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figure25.1%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $27.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Revenue: $108.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001492298-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure35.0%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $40.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Revenue: $116.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure(19.6%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$25.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Revenue: $128.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure
Diluted EPS$ per share0.13Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figurenot reported (Diluted EPS not reported)0.17Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure0.27Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure0.09Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001492298-25-000039.Report this figurenot reported (Diluted EPS not reported)0.16Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-29, accession 0001492298-26-000012.Report this figure(0.10)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001492298-26-000028.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$356.9mNet margin 43.6%
Diluted EPS$0.64, FY2025
Sabra Health Care REIT, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m156Revenue, FY2021, twelve months to 2021-12-31$155.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0001492298-24-000008.Report this figure187Revenue, FY2022, twelve months to 2022-12-31$186.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-19, accession 0001492298-25-000008.Report this figure236Revenue, FY2023, twelve months to 2023-12-31$236.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001492298-26-000008.Report this figure285Revenue, FY2024, twelve months to 2024-12-31$284.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001492298-26-000008.Report this figure357Revenue, FY2025, twelve months to 2025-12-31$356.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001492298-26-000008.Report this figure
Gross margin%not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)not reported (Gross profit not reported)
Operating margin%not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)not reported (Operating income not reported)
Net margin%(72.8%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$113.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-27, accession 0001492298-24-000008.Revenue: $155.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0001492298-24-000008.Report this figure(41.6%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$77.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-19, accession 0001492298-25-000008.Revenue: $186.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-19, accession 0001492298-25-000008.Report this figure5.8%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $13.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001492298-26-000008.Revenue: $236.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001492298-26-000008.Report this figure44.5%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $126.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001492298-26-000008.Revenue: $284.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001492298-26-000008.Report this figure43.6%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $155.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-12, accession 0001492298-26-000008.Revenue: $356.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-12, accession 0001492298-26-000008.Report this figure
Diluted EPS$ per share(0.52)Diluted EPS, FY2021, twelve months to 2021-12-31−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-27, accession 0001492298-24-000008.Report this figure(0.34)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-19, accession 0001492298-25-000008.Report this figure0.06Diluted EPS, FY2023, twelve months to 2023-12-31$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-12, accession 0001492298-26-000008.Report this figure0.54Diluted EPS, FY2024, twelve months to 2024-12-31$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-12, accession 0001492298-26-000008.Report this figure0.64Diluted EPS, FY2025, twelve months to 2025-12-31$0.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-12, accession 0001492298-26-000008.Report this figure
Free cash flow$mnot reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)not reported (Capital expenditure not reported)

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Sabra Health Care REIT, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$811.9m41,614,351Added+2,515,962
PRINCIPAL FINANCIAL GROUP INC2026-06-30$482.0m24,706,070Reduced−346,051
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$455.6m23,352,373Added+209,125
STATE STREET CORP2026-06-30$240.1m12,305,655Added+205,704
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$221.4m11,349,125Added+118,377
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$154.3m7,909,172Added+458,403
CENTERSQUARE INVESTMENT MANAGEMENT LLC2026-06-30$113.4m5,814,427Added+1,936,617
BANK OF AMERICA CORP /DE/2026-06-30$103.4m5,300,762Reduced−108,399
CHARLES SCHWAB INVESTMENT MANAGEMENT INC2026-06-30$94.4m4,840,401Added+67,098
Nuveen, LLC2026-06-30$87.1m4,464,764Reduced−2,208,520

Recent filings

All 1,573 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Sabra Health Care REIT, Inc., recent filings
FiledFormWhat it isAccession number
2026-08-0316:06 ET10-QQuarterly reportPeriod 2026-06-300001492298-26-000028
2026-08-0316:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001492298-26-000027
2026-07-2109:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001492298-26-000023
2026-06-1716:40 ET8-K5.07 Shareholder vote results0001492298-26-000019
2026-05-2816:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001492298-26-000014
2026-04-2916:06 ET10-QQuarterly reportPeriod 2026-03-310001492298-26-000012
2026-04-2916:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001492298-26-000011
2026-04-2409:06 ETDEF 14AProxy statementPeriod 2026-06-170001193125-26-175398
2026-02-1216:07 ET10-KAnnual reportPeriod 2025-12-310001492298-26-000008
2026-02-1216:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001492298-26-000007

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 12, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1492298
Tickers
SBRA
Exchange
Nasdaq
SIC code
6798 Real Estate Investment Trusts
Sector
Real estate
Fiscal year ends
Dec 31
Incorporated in
MD
Filer category
Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:41 ET. Listed shows no prices and gives no investment advice.